Abstract
We report a case of successful treatment with tolvaptan (15 mg/day) in a 73-year-old female patient with chronic kidney disease (CKD) stage 5 due to diabetic nephropathy and renal sclerosis for volume control and loop diuretic-induced hyponatremia. Her creatinine clearance has remained at 7-10 ml/min for the last 6 months. She was treated by dietary and drug therapy, namely, antihypertensives (nifedipine: 40 mg/day, olmesartan: 20 mg/day) and loop diuretics (azosemide: 40-120 mg/day), for CKD and concomitant diseases of hypertension and diabetic mellitus. She developed loop diuretic-induced hyponatremia (120 mmol/l) by increased sodium excretion, but the diuretic was required for the control of volume overload. Hence, azosemide was suspended and tolvaptan (15 mg/day) was administered. After tolvaptan treatment, the plasma sodium level gradually increased to a normal level (135-140 mmol/l) and volume overload was improved. Urine volume was maintained at about 1000 ml/day with low sodium excretion (<40 mmol/day) and increased free water clearance. These results suggest that tolvaptan may be effective for volume control and diuretic-induced hyponatremia in CKD patients.
References
Dec 1, 1996·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·V M BuckalewG Schulman
Jan 16, 2002·Journal of Hypertension·Robert A AugustyniakRonald G Victor
Sep 15, 2004·Journal of the American College of Cardiology·John M McCurleyMark C Haigney
Jan 25, 2006·Clinical Nephrology·C-C WuK-C Lu
Feb 28, 2006·Kidney International·F IrieT Nose
Apr 12, 2006·Archives of Internal Medicine·Alexander GoldbergDoron Aronson
Apr 19, 2006·Gastroenterology·Maria-Carlota LondoñoPere Ginès
Nov 16, 2006·The New England Journal of Medicine·Robert W SchrierUNKNOWN SALT Investigators
Mar 27, 2007·JAMA : the Journal of the American Medical Association·Marvin A KonstamUNKNOWN Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators
Aug 25, 2009·The American Journal of Medicine·Sushrut S WaikarGary C Curhan
Feb 27, 2010·Journal of the American Society of Nephrology : JASN·Tomas BerlUNKNOWN SALTWATER Investigators
May 6, 2011·Kidney International·Maria V IrazabalFrank S Czerwiec
Sep 10, 2011·Clinical Journal of the American Society of Nephrology : CJASN·Eiji HigashiharaUNKNOWN TEMPOFormula and 156-05-002 Study Investigators